在全国艾滋病控制计划下针对性干预计划在印度各地注射毒品使用者的有效性评估
Damodar Sahu1, Varsha Ranjan2, Nishakar Thakur3
1Scientist F, ICMR-National Institute of Medical Statistics, New Delhi, India.
Indian journal of public health
|July 17, 2023
概括
针对性干预 (TI) 计划有效地减少了印度注射毒品使用者 (IDU) 中的针头/注射器共享. 这种艾滋病毒预防策略增加了新针的使用,减少了共享,尽管该计划的覆盖范围因地区而异.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 行为科学 行为科学
背景情况:
- 在注射毒品使用者 (IDU) 中艾滋病毒的高流行率是印度的一个重大问题.
- 药物注射者是集中艾滋病毒流行病的关键驱动因素.
- 有针对性的干预 (TI) 计划旨在减轻这一群体的风险行为.
研究的目的:
- 评估TI计划对印度注射剂使用者风险行为的有效性.
- 评估TI对针头/注射器使用和共享实践的影响.
- 分析TI计划有效性的区域差异.
主要方法:
- 利用了 2014-2015 年 IDU 综合生物和行为监测数据.
- 员工描述性统计和倾向性得分匹配分析.
- 考虑了共变量来确定平均治疗对受治疗者的影响 (ATT).
主要成果:
- 从同行教育者/外展工作者 (PE/ORWs) 收到新针/注射器的注射使用者显示,新针/注射器使用量增加了2.8%.
- 在那些从PE/ORWs获得供应的人群中,针/注射器共享率下降了6.5%.
- 在整个印度,在计划有效性方面发现了显著的区域差异.
结论:
- 该TI计划有效地促进了IDU的行为变化,其证据是增加了新针的使用和减少了共享.
- 建议扩大TI计划覆盖范围,以加速艾滋病毒/艾滋病预防服务.
- 解决TI计划覆盖范围的区域差异对于全面的艾滋病毒预防至关重要.
更多相关视频
23:56Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
16.8K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.3K
相关概念视频
Community Based Intervention
66
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
66
Dose-Response Relationship: Potency and Efficacy
4.6K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K
Pulmonary Tuberculosis V
204
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
204
Pulmonary Tuberculosis I
270
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
270
Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
